Most sold healthcare stocks in Q1 2024
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2024, measured as net reductions in reported share positions from Q4 2023 into Q1 2024. Notable reductions at the top of this list include GILEAD SCIENCES INC (GILD), TEVA PHARMACEUTICAL-SP ADR (TEVA), PFIZER INC (PFE), TELADOC HEALTH INC (TDOC). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | -11,946,321 | -$1.14B | 0 | 2 | 6 | 1 | 8 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -5,460,109 | -$51.91M | 0 | 2 | 3 | 2 | 5 |
| PFE | PFIZER INC | -5,056,711 | -$107.84M | 1 | 5 | 6 | 2 | 14 |
| TDOC | TELADOC HEALTH INC | -4,531,576 | -$215.29M | 0 | 1 | 1 | 0 | 2 |
| VKTX | VIKING THERAPEUTICS INC | -4,050,172 | -$5.97M | 0 | 0 | 1 | 0 | 1 |
| VTRS | VIATRIS INC | -3,379,390 | -$36.91M | 1 | 0 | 3 | 1 | 4 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -3,262,196 | $205.98M | 1 | 0 | 3 | 0 | 6 |
| EWTX | EDGEWISE THERAPEUTICS INC | -2,839,300 | -$6.47M | 0 | 0 | 2 | 0 | 2 |
| QSI | QUANTUM-SI INC | -2,750,446 | -$6.04M | 0 | 0 | 1 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | -2,735,120 | -$221.28M | 0 | 2 | 1 | 1 | 3 |
| HOLX | HOLOGIC INC | -2,554,519 | -$80.75M | 0 | 2 | 3 | 0 | 6 |
| AMLX | AMYLYX PHARMACEUTICALS INC | -2,329,243 | -$43.61M | 0 | 1 | 0 | 1 | 1 |
| BFLY | BUTTERFLY NETWORK INC | -2,220,441 | -$2.59M | 0 | 1 | 1 | 0 | 2 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -2,192,634 | -$79.54M | 1 | 0 | 1 | 0 | 3 |
| WRBY | WARBY PARKER INC-CLASS A | -2,087,132 | -$34.26M | 0 | 1 | 2 | 0 | 3 |
| DHR | DANAHER CORP | -2,053,114 | -$134.19M | 0 | 2 | 5 | 3 | 12 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | -1,783,167 | -$3.49M | 1 | 0 | 1 | 0 | 2 |
| RCM | R1 RCM INC | -1,760,800 | -$18.52K | 0 | 0 | 1 | 0 | 1 |
| CDNA | CAREDX INC | -1,394,276 | -$27.17M | 0 | 1 | 2 | 0 | 3 |
| THC | TENET HEALTHCARE CORP | -1,335,654 | -$96.49M | 0 | 0 | 1 | 1 | 1 |
| COYA | COYA THERAPEUTICS INC | -1,274,026 | -$9.44M | 0 | 0 | 0 | 1 | 0 |
| GSK | GSK PLC-SPON ADR | -1,250,189 | $396.23M | 0 | 2 | 4 | 1 | 6 |
| MCK | MCKESSON CORP | -1,244,759 | -$481.82M | 2 | 1 | 4 | 1 | 7 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -1,214,136 | -$213.65M | 0 | 0 | 1 | 0 | 1 |
| BEAM | BEAM THERAPEUTICS INC | -1,211,715 | $14.64M | 0 | 0 | 1 | 0 | 1 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | -1,190,100 | -$2.94K | 0 | 0 | 1 | 0 | 1 |
| ACCD | ACCOLADE INC | -1,166,765 | -$22.91M | 0 | 1 | 1 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | -1,127,283 | $757 | 0 | 0 | 1 | 0 | 1 |
| ABBV | ABBVIE INC | -1,092,070 | -$20.20M | 0 | 2 | 6 | 0 | 12 |
| KPTI | KARYOPHARM THERAPEUTICS INC | -1,057,577 | -$330 | 0 | 0 | 1 | 0 | 1 |
| ASRT | ASSERTIO HOLDINGS INC | -1,050,555 | -$1.35K | 0 | 0 | 1 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | -1,043,012 | -$132.80M | 0 | 4 | 7 | 2 | 16 |
| VERV | VERVE THERAPEUTICS INC | -949,880 | -$17.71M | 0 | 1 | 1 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | -918,330 | -$166.69M | 0 | 2 | 5 | 1 | 9 |
| AGL | AGILON HEALTH INC | -915,858 | -$20.44M | 0 | 1 | 2 | 0 | 3 |
| MCRB | SERES THERAPEUTICS INC | -817,000 | -$1.14K | 0 | 0 | 0 | 1 | 0 |
| BAX | BAXTER INTERNATIONAL INC | -794,753 | $233.16M | 0 | 4 | 3 | 0 | 9 |
| CAH | CARDINAL HEALTH INC | -788,384 | -$39.95M | 0 | 0 | 5 | 0 | 7 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -783,393 | -$47.11M | 1 | 1 | 3 | 2 | 5 |
| TSHA | TAYSHA GENE THERAPIES INC | -768,900 | -$999 | 0 | 0 | 1 | 0 | 1 |
| NKTR | NEKTAR THERAPEUTICS | -704,794 | $1.31K | 0 | 0 | 1 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | -697,111 | -$134.35M | 0 | 3 | 3 | 1 | 6 |
| SGRY | SURGERY PARTNERS INC | -644,740 | -$31.69M | 0 | 1 | 1 | 0 | 2 |
| INCY | INCYTE CORP | -640,672 | -$140.24M | 1 | 1 | 2 | 0 | 4 |
| A | AGILENT TECHNOLOGIES INC | -611,199 | -$60.92M | 0 | 1 | 3 | 0 | 5 |
| GANX | GAIN THERAPEUTICS INC | -584,510 | -$1.92M | 0 | 1 | 0 | 1 | 1 |
| PINC | PREMIER INC-CLASS A | -573,055 | -$12.96K | 0 | 0 | 1 | 0 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | -567,649 | -$38.17M | 0 | 1 | 2 | 0 | 3 |
| ELV | ELEVANCE HEALTH INC | -566,774 | $220.94M | 0 | 3 | 7 | 0 | 12 |
| SGMO | SANGAMO THERAPEUTICS INC | -547,901 | $32 | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q1 2024
What are the most sold Healthcare stocks in Q1 2024?
The most sold healthcare stocks in Q1 2024 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q4 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2024?
Among the managers we track, net reductions were largest in companies such as GILEAD SCIENCES INC (GILD), TEVA PHARMACEUTICAL-SP ADR (TEVA), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2023).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.